Of the selected genes, DNAJC12, FABP5, and BOP1 were the most consistently upregulated in prostate tumors compared to normal prostate tissues in the dataset collection (Figure 5A-5C), with significant upregulation of DNAJC12 in 6 of the 14 datasets (Figure 5A), FABP5 in 14 of the 16 data sets (Figure 5B), and BOP1 in 7 of the 14 datasets (Figure 5C). This evidence concerns the gene FABP5 and prostate neoplasm.